IVF HARTMANN Holding AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0187624256
CHF
138.00
-1 (-0.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 9.93%

  • The company has been able to generate a Return on Equity (avg) of 9.93% signifying low profitability per unit of shareholders funds
2

Company has a low Debt to Equity ratio (avg) at times

 
3

Poor long term growth as Operating profit has grown by an annual rate 6.30% of over the last 5 years

 
4

The company has declared Positive results for the last 4 consecutive quarters

5

With ROE of 13.08%, it has a Expensive valuation with a 2.26 Price to Book Value

6

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 334 Million ()

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.46%

stock-summary
Debt Equity

-0.62

stock-summary
Return on Equity

13.08%

stock-summary
Price to Book

2.29

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.36%
0%
0.36%
6 Months
-4.17%
0%
-4.17%
1 Year
-8.61%
0%
-8.61%
2 Years
26.61%
0%
26.61%
3 Years
23.21%
0%
23.21%
4 Years
11.29%
0%
11.29%
5 Years
-24.59%
0%
-24.59%

IVF HARTMANN Holding AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.37%
EBIT Growth (5y)
6.30%
EBIT to Interest (avg)
16.80
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.71
Sales to Capital Employed (avg)
1.07
Tax Ratio
15.78%
Dividend Payout Ratio
37.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.75%
ROE (avg)
9.93%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.26
EV to EBIT
10.77
EV to EBITDA
8.72
EV to Capital Employed
4.36
EV to Sales
1.49
PEG Ratio
2.21
Dividend Yield
4.53%
ROCE (Latest)
40.51%
ROE (Latest)
13.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Bearish
Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by IVF HARTMANN Holding AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -1.73% vs 4.51% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 34.82% vs 80.65% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "148.00",
          "val2": "150.60",
          "chgp": "-1.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.60",
          "val2": "16.10",
          "chgp": "9.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.30",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.10",
          "val2": "11.20",
          "chgp": "34.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "82.10%",
          "val2": "66.60%",
          "chgp": "1.55%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
148.00
150.60
-1.73%
Operating Profit (PBDIT) excl Other Income
17.60
16.10
9.32%
Interest
0.00
0.30
-100.00%
Exceptional Items
-0.10
-0.10
Consolidate Net Profit
15.10
11.20
34.82%
Operating Profit Margin (Excl OI)
82.10%
66.60%
1.55%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -1.73% vs 4.51% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 34.82% vs 80.65% in Dec 2022

stock-summaryCompany CV
About IVF HARTMANN Holding AG stock-summary
stock-summary
IVF HARTMANN Holding AG
Pharmaceuticals & Biotechnology
IVF HARTMANN Holding AG (IVF) is a Switzerland-based holding company engaged in the field of medical supplies. The Company's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The Company also offers consulting services, on-site or in classrooms, related to the usage of its products. The Company's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. It also operates subsidiaries located in Switzerland.
Company Coordinates stock-summary
Company Details
Victor-von-Bruns-Strasse 28 , NEUHAUSEN AM RHEINFALL None : 8212
stock-summary
Tel: 41 52 6743111
stock-summary
stock-summary
Registrar Details